While BAP1’s role as a tumor suppressor is well-established in breast cancer [72], malignant mesothelioma [43, 73], and uveal melanoma [74, 75], its involvement in targeted therapy-induced apoptosis is novel. Here, BAP1 is linked to breast carcinoma.